Gene Therapy - Table of Contents alert Volume 23 Issue 3

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 23, Issue 3 (March 2016) In this issue Original Articles Short Communication Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Visit us at the American College of Medical Genetics and Genomics (ACMG) Annual  Meeting Pick up complimentary copies of Genetics in Medicine and other top Nature journals at booth #826 in Tampa, Florida - March 8-12th. We will also have free giveaways and an opportunity to hear the latest GenePod from Editor-in-Chief Jim Evans talking about the ACMG 25th anniversary. Find out more Original Articles Top Co-expression of fibulin-5 and VEGF165 increases long-term patency of synthetic vascular grafts seeded with autologous endothelial cells M Preis, J Schneiderman, B Koren, Y Ben-Yosef, D Levin-Ashkenazi, S Shapiro, T Cohen, M Blich, M Israeli-Amit, Y Sarnatzki, D Gershtein, R Shofti, B S Lewis, Y Shaul and M Y Flugelman Gene Ther 2016 23: 237-246; advance online publication, December 24, 2015; 10.1038/gt.2015.104 Abstract | Full Text rAAV-mediated overexpression of sox9, TGF-β and IGF-I in minipig bone marrow aspirates to enhance the chondrogenic processes for cartilage repair J Frisch, A Rey-Rico, J K Venkatesan, G Schmitt, H Madry and M Cucchiarini Gene Ther 2016 23: 247-255; advance online publication, November 19, 2015; 10.1038/gt.2015.106 Abstract | Full Text A novel intranuclear RNA vector system for long-term stem cell modification Y Ikeda, A Makino, W E Matchett, S J Holditch, B Lu, A B Dietz and K Tomonaga Gene Ther 2016 23: 256-262; advance online publication, December 3, 2015; 10.1038/gt.2015.108 Abstract | Full Text Mucopolysaccharidosis IIIB confers enhanced neonatal intracranial transduction by AAV8 but not by 5, 9 or rh10 OPEN J A Gilkes, M D Bloom and C D Heldermon Gene Ther 2016 23: 263-271; advance online publication, December 16, 2015; 10.1038/gt.2015.111 Abstract | Full Text Healthy and diseased corticospinal motor neurons are selectively transduced upon direct AAV2-2 injection into the motor cortex OPEN J H Jara, M J Stanford, Y Zhu, M Tu, W W Hauswirth, M C Bohn, S H DeVries and P H Özdinler Gene Ther 2016 23: 272-282; advance online publication, January 21, 2016; 10.1038/gt.2015.112 Abstract | Full Text AAV1/2-mediated BDNF gene therapy in a transgenic rat model of Huntington’s disease B Connor, Y Sun, D von Hieber, S K Tang, K S Jones and C Maucksch Gene Ther 2016 23: 283-295; advance online publication, December 24, 2015; 10.1038/gt.2015.113 Abstract | Full Text Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart M Merentie, L Lottonen-Raikaslehto, V Parviainen, J Huusko, S Pikkarainen, M Mendel, N Laham-Karam, V Kärjä, R Rissanen, M Hedman and S Ylä-Herttuala Gene Ther 2016 23: 296-305; advance online publication, December 24, 2015; 10.1038/gt.2015.114 Abstract | Full Text Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia M R Kibbe, A T Hirsch, F O Mendelsohn, M G Davies, H Pham, J Saucedo, W Marston, W-B Pyun, S-K Min, B G Peterson, A Comerota, D Choi, J Ballard, R A Bartow, D W Losordo, W Sherman, V Driver and E C Perin Gene Ther 2016 23: 306-312; advance online publication, December 8, 2015; 10.1038/gt.2015.110 Abstract | Full Text Short Communication Top Prevalence of AAV1 neutralizing antibodies and consequences for a clinical trial of gene transfer for advanced heart failure B Greenberg, J Butler, G M Felker, P Ponikowski, A A Voors, J M Pogoda, R Provost, J Guerrero, R J Hajjar and K M Zsebo Gene Ther 2016 23: 313-319; advance online publication, December 24, 2015; 10.1038/gt.2015.109 Abstract | Full Text Corrigendum Top Efficient delivery of lentiviral vectors into resting human CD4 T cells X Geng, G Doitsh, Z Yang, N L K Galloway and W C Greene Gene Ther 2016 23: 320-322; 10.1038/gt.2015.115 Full Text Advertisement Why not submit your research to Gene Therapy? We are actively considering and viewing papers on stem cells, gene modifying, disease models, nanotechnology and genetic diseases. Use our easy and quick online submission system where articles are put through our rapid and rigours peer review process. Once accepted, they are published online within 72 hours. Click here to submit today   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.